StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
186
This year
1
Publishing Date
2023 - 06 - 28
2
2023 - 05 - 24
2
2023 - 04 - 28
2
2023 - 04 - 21
2
2023 - 04 - 05
2
2023 - 03 - 16
3
2023 - 02 - 22
2
2023 - 02 - 21
2
2023 - 02 - 03
2
2022 - 12 - 08
2
2022 - 11 - 04
2
2022 - 10 - 24
2
2022 - 10 - 21
2
2022 - 10 - 05
8
2022 - 10 - 04
3
2022 - 09 - 29
2
2022 - 09 - 26
2
2022 - 09 - 21
2
2022 - 09 - 14
2
2022 - 09 - 06
2
2022 - 07 - 28
2
2022 - 07 - 12
2
2022 - 07 - 06
2
2022 - 06 - 24
2
2022 - 06 - 21
2
2022 - 06 - 09
3
2022 - 06 - 07
1
2022 - 06 - 06
2
2022 - 06 - 05
1
2022 - 06 - 03
1
2022 - 06 - 01
3
2022 - 05 - 27
1
2022 - 05 - 26
1
2022 - 05 - 25
1
2022 - 05 - 24
1
2022 - 05 - 18
1
2022 - 05 - 17
3
2022 - 05 - 05
2
2022 - 05 - 02
2
2022 - 05 - 01
1
2022 - 04 - 29
2
2022 - 04 - 28
1
2022 - 04 - 27
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 04 - 20
1
2022 - 04 - 13
1
2022 - 04 - 12
2
2022 - 04 - 11
1
2022 - 04 - 07
2
2022 - 04 - 06
3
2022 - 04 - 04
1
2022 - 04 - 01
1
2022 - 03 - 29
1
2022 - 03 - 25
1
2022 - 01 - 23
1
2021 - 11 - 07
1
2021 - 05 - 01
2
2021 - 04 - 17
1
2021 - 04 - 03
1
Sector
Commercial services
2
Communications
2
Consumer durables
4
Consumer non-durables
1
Consumer services
2
Distribution services
2
Electronic technology
4
Energy minerals
3
Finance
10
Health care and social assistance
1
Health services
4
Health technology
104
Industrial services
2
Information
1
Manufacturing
10
Mining, quarrying, and oil and gas extraction
1
N/a
9
Non-energy minerals
2
Process industries
2
Producer manufacturing
1
Professional, scientific, and technical services
9
Technology services
6
Utilities
1
Tags
Acquisition
2
Asco
4
Association
3
Biocanada
2
Biopharma
4
Bioscience
2
Biotech
3
Biotech-bay
3
Biotech-beach
3
Business
2
Cancer
14
Cell
4
Conference
4
Day
2
Diabetes
4
Disease
5
Drug
2
Energy
2
Events
20
Fda
5
Genetown
2
Group
2
Health
2
Hepatitis
2
Imaging
2
Immunology
4
Immunotherapy
10
International
4
Liver
3
Medical
3
Meeting
117
Melanoma
2
Molecular
3
N/a
140
Nyx-783
2
Olinvyk
2
Pharm-country
5
Pharma
6
Pharmaceuticals
12
Phase 2
5
Phase 2b
2
Phase 3
2
Positive
5
Potential
3
Pre-clinical
9
Preclinical
10
Presentation
23
Program
9
Proposal
2
Research
14
Results
19
Solution
2
Spring
2
Study
7
Technology
4
Therapeutics
18
Therapy
5
Treatment
5
Trial
8
Update
4
Entities
Aarons holdings company, inc.
1
Abbvie inc.
1
Abeona therapeutics inc.
1
Acasti pharma, inc.
1
Adial pharmaceuticals, inc
1
Akoya biosciences inc
2
Aligos therapeutics, inc.
1
Alkermes plc
1
Ameriserv financial inc.
2
Amgen inc.
1
Applied therapeutics, inc.
1
Aptevo therapeutics inc.
1
Aptinyx inc.
2
Arcutis biotherapeutics, inc.
1
Ardelyx, inc.
1
Arrival
1
Ascendis pharma a/s
1
Aslan pharmaceuticals limited
1
Athersys, inc.
1
Avadel pharmaceuticals plc
1
Avista public acquisition corp. ii
1
Axogen, inc.
1
Axsome therapeutics, inc.
2
Bausch & lomb corp
2
Bausch health companies inc.
1
Beigene, ltd.
1
Bellicum pharmaceuticals, inc.
1
Bellus health inc.
1
Benefitfocus, inc.
1
Bicycle therapeutics plc
1
Bio-key international, inc.
1
Biocryst pharmaceuticals, inc.
1
Bionano genomics, inc.
1
Bluelinx holdings inc.
1
Boston scientific corporation
1
Brookfield asset management inc
1
Can-fite biopharma ltd
1
Caredx, inc.
1
Catalyst pharmaceuticals, inc.
1
Cellcom israel ltd.
1
Celldex therapeutics, inc.
1
Cellectar biosciences, inc.
1
Centene corporation
1
Clearside biomedical, inc.
3
Duke realty corporation
2
Eyenovia, inc.
2
Hepion pharmaceuticals, inc.
2
Ionis pharmaceuticals, inc.
2
Nikola corporation
2
Norwood financial corp.
2
Oncolytics biotech inc.
2
Panbela therapeutics inc
2
Prologis, inc.
2
Rocket pharmaceuticals, inc.
2
Sanofi
2
Tff pharmaceuticals, inc.
2
Trevena, inc.
2
Vishay intertechnology, inc.
2
Xenon pharmaceuticals inc.
2
Zai lab limited
2
Symbols
AAN
1
ABBV
1
ABEO
1
ACST
1
ADIL
1
AHPA
1
AKYA
2
ALGS
1
ALKS
1
AMGN
1
APLT
1
APTX
2
APVO
1
ARDX
1
ARQT
1
ARVL
1
ASLN
1
ASND
1
ASRV
2
ATHX
1
AVDL
1
AXGN
1
AXSM
2
BAM
1
BCRX
1
BCYC
1
BEIGF
1
BGNE
1
BHC
1
BKYI
1
BLCM
1
BLCO
2
BLU
1
BNFT
1
BNGO
1
BSX
1
BXC
1
CANF
1
CDNA
1
CELJF
1
CHRS
1
CIIG
1
CLSD
3
DRE
2
EYEN
2
HEPA
2
IONS
2
NKLA
2
NWFL
2
ONCY
2
PBLA
2
PLD
2
RCKT
2
SNY
2
SNYNF
2
TFFP
2
TRVN
2
VSH
2
XENE
2
ZLAB
2
Exchanges
Amex
3
Nasdaq
160
Nyse
26
Crawled Date
2023 - 06 - 28
2
2023 - 05 - 24
2
2023 - 04 - 28
2
2023 - 04 - 21
2
2023 - 04 - 05
2
2023 - 03 - 16
3
2023 - 02 - 22
2
2023 - 02 - 21
2
2023 - 02 - 03
2
2022 - 12 - 08
2
2022 - 11 - 04
2
2022 - 10 - 24
2
2022 - 10 - 21
2
2022 - 10 - 05
8
2022 - 10 - 04
3
2022 - 09 - 29
2
2022 - 09 - 26
2
2022 - 09 - 21
2
2022 - 09 - 14
2
2022 - 09 - 06
2
2022 - 07 - 28
2
2022 - 07 - 12
2
2022 - 07 - 06
2
2022 - 06 - 24
2
2022 - 06 - 21
2
2022 - 06 - 09
3
2022 - 06 - 07
1
2022 - 06 - 06
2
2022 - 06 - 05
1
2022 - 06 - 03
1
2022 - 06 - 01
3
2022 - 05 - 27
1
2022 - 05 - 26
1
2022 - 05 - 25
1
2022 - 05 - 24
1
2022 - 05 - 18
1
2022 - 05 - 17
3
2022 - 05 - 05
2
2022 - 05 - 02
2
2022 - 05 - 01
1
2022 - 04 - 29
2
2022 - 04 - 28
1
2022 - 04 - 27
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 04 - 20
1
2022 - 04 - 13
1
2022 - 04 - 12
2
2022 - 04 - 11
1
2022 - 04 - 07
2
2022 - 04 - 06
3
2022 - 04 - 04
1
2022 - 04 - 01
1
2022 - 03 - 29
1
2022 - 03 - 25
1
2022 - 01 - 23
1
2021 - 11 - 07
1
2021 - 05 - 01
2
2021 - 04 - 17
1
2021 - 04 - 03
1
Crawled Time
00:00
170
00:09
2
00:12
2
00:20
43
01:00
109
02:00
42
03:00
38
04:00
13
04:20
20
05:00
36
06:00
51
07:00
68
08:00
61
08:20
3
09:00
76
09:05
2
10:00
136
10:41
7
11:00
392
12:00
788
12:01
10
12:03
4
12:15
86
12:20
186
12:30
107
13:00
664
13:01
4
13:03
8
13:04
4
13:15
62
13:20
169
13:30
108
14:00
457
14:01
4
14:15
39
14:20
100
14:30
70
15:00
222
15:01
10
15:15
36
15:20
68
15:30
50
16:00
179
16:20
72
17:00
245
18:00
200
19:00
173
19:07
3
20:00
344
20:20
47
21:00
653
22:00
532
22:01
6
22:02
3
22:04
5
22:07
7
22:08
4
22:14
4
23:00
290
23:07
4
Source
contravir.com
2
investors.senseibio.com
1
www.biospace.com
46
www.globenewswire.com
97
www.precisionbiosciences.com
1
www.prnewswire.com
39
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
meeting
crawled time :
12:20
save search
YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting
Published:
2024-02-18
(Crawled : 12:20)
- prnewswire.com
YS
|
$0.814
0.38%
0.38%
24K
|
n/a
|
Email alert
Add to watchlist
biopharma
meeting
results
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published:
2023-11-04
(Crawled : 12:20)
- globenewswire.com
FNCTF
|
News
|
$11.16
-20.84%
130
|
Communications
|
Email alert
Add to watchlist
gda-201
candidate
natural
cancer
cell
immunotherapy
meeting
therapy
ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints
Published:
2023-08-27
(Crawled : 12:20)
- prnewswire.com
BSX
|
$72.91
5.68%
-0.03%
15M
|
Health Technology
|
Email alert
Add to watchlist
system
study
FSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023
Published:
2023-08-15
(Crawled : 12:20)
- biospace.com/
HUGE
|
News
|
$0.4634
-5.24%
-5.52%
280K
|
Process Industries
|
-65.41%
|
O:
-3.11%
H:
9.29%
C:
2.14%
pharma
lucid-ms
meeting
Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting
Published:
2023-08-07
(Crawled : 12:20)
- globenewswire.com
EVOK
|
$0.433
-2.37%
-2.42%
9K
|
Health Technology
|
-70.59%
|
O:
0.0%
H:
0.0%
C:
-7.84%
pharma
eversana
meeting
Precision BioSciences Provides Updates on Azer-Cel FDA Meeting, Potential Partnerships and Timing of In Vivo R&D Day
Published:
2023-07-27
(Crawled : 12:20)
- precisionbiosciences.com
DTIL
|
$9.81
-4.11%
-4.28%
34K
|
Health Technology
|
1578.63%
|
O:
0.85%
H:
3.31%
C:
-4.07%
day
fda
potential
Immix Biopharma Subsidiary Nexcella Announces NXC-201 Multiple Myeloma Clinical Data Abstract Accepted for Presentation at the 20th International Myeloma Society Annual Meeting
Published:
2023-07-25
(Crawled : 12:20)
- globenewswire.com
IMMX
|
$2.15
-6.52%
-6.98%
60K
|
|
2.9%
|
O:
-1.45%
H:
5.15%
C:
0.49%
nxc-201
presentation
international
biopharma
meeting
Moxian to Hold Annual Meeting of Shareholders on August 25, 2023
Published:
2023-07-18
(Crawled : 12:20)
- globenewswire.com
MOXC
|
$1.01
0.99%
66K
|
Technology Services
|
5.77%
|
O:
-0.32%
H:
4.01%
C:
4.01%
meeting
Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings
Published:
2023-07-11
(Crawled : 12:20)
- globenewswire.com
ADIL
|
News
|
$1.72
1.18%
1.16%
140K
|
Health Technology
|
745.28%
|
O:
8.4%
H:
155.36%
C:
75.56%
business
favorable
update
Genesis Unicorn Capital Corp. Announces Filing and Mailing of Definitive Proxy Statement and Special Meeting Date for Proposed Business Combination with Environmental Solutions Group Holdings Limited
Published:
2023-07-07
(Crawled : 12:20)
- globenewswire.com
GENQ
|
$10.47
23.06%
90K
|
n/a
|
-2.15%
|
O:
-0.37%
H:
0.0%
C:
-0.09%
business
group
solutions
meeting
Cellectar Biosciences Highlights Promising Interim Data from Its Ongoing Study of Iopofosine I 131 in Multiple Myeloma in an Oral Presentation at the SNMMI Annual Meeting
Published:
2023-06-28
(Crawled : 12:20)
- globenewswire.com
CLRB
|
$3.045
-2.09%
-2.13%
1M
|
Health Technology
|
66.3%
|
O:
3.67%
H:
0.65%
C:
-3.02%
presentation
ongoing
meeting
study
ReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meeting
Published:
2023-06-28
(Crawled : 12:20)
- globenewswire.com
RSLS
|
$0.1705
3.93%
120K
|
Manufacturing
|
-88.74%
|
O:
-1.32%
H:
0.81%
C:
-5.37%
lifesciences
device
meeting
diabetes
Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes
Published:
2023-06-26
(Crawled : 12:20)
- globenewswire.com
PBLA
|
News
|
$0.42
-6.31%
64K
|
Professional, Scientific, and T...
|
-81.7%
|
O:
0.89%
H:
0.73%
C:
-9.29%
presentation
endocrine
diabetes
Quirk Auto Group selects BIO-key’s PortalGuard® Cloud Solution to Meet Updated GLBA Act Safeguards Rule Requirements to Protect Consumer Data
Published:
2023-06-20
(Crawled : 12:20)
- globenewswire.com
BKYI
|
News
|
$1.64
-4.4%
14K
|
Technology Services
|
122.38%
|
O:
-1.4%
H:
6.37%
C:
6.24%
portalguard
solution
group
cloud
Voting Results from Constellium’s 2023 Annual General Meeting
Published:
2023-06-16
(Crawled : 12:20)
- globenewswire.com
CSTM
|
$19.99
-6.28%
1.05%
2.5M
|
Commercial Services
|
19.06%
|
O:
0.89%
H:
0.12%
C:
-1.59%
meeting
results
Navitas to Present Next-Gen GaN & SiC Semiconductors at Taiwan Investor Meeting
Published:
2023-06-09
(Crawled : 12:20)
- globenewswire.com
NVTS
|
$4.135
9.1%
8.34%
2.6M
|
Manufacturing
|
-55.69%
|
O:
0.64%
H:
0.91%
C:
-1.39%
meeting
Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting
Published:
2023-06-05
(Crawled : 12:20)
- globenewswire.com
PRTG
|
$0.265
9.23%
8.45%
180K
|
Mining, Quarrying, and Oil and ...
|
-93.15%
|
O:
2.47%
H:
17.65%
C:
0.8%
lung
melanoma
biotech
cancer
cell
treatment
meeting
trial
Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting: Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 Diabetes
Published:
2023-06-01
(Crawled : 12:20)
- globenewswire.com
PBLA
|
News
|
$0.42
-6.31%
64K
|
Professional, Scientific, and T...
|
-93.93%
|
O:
2.03%
H:
0.0%
C:
0.0%
presentation
immunology
diabetes
potential
DIRTT Announces Results of Annual and Special Meeting of Shareholders; Leadership Changes
Published:
2023-05-31
(Crawled : 12:20)
- globenewswire.com
DRTT
|
News
|
$0.3343
-14.78%
260K
|
Consumer Durables
|
-11.4%
|
O:
-7.24%
H:
8.09%
C:
3.54%
meeting
results
Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting
Published:
2023-05-30
(Crawled : 12:20)
- biospace.com/
MRNA
|
News
S
|
$108.82
0.86%
0.85%
3.4M
|
Health Technology
|
-13.78%
|
O:
0.18%
H:
2.19%
C:
1.91%
rna-4157
asco
meeting
← Previous
1
2
3
4
5
6
7
8
9
10
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.